News & Events
-
April 22, 2020 - April 23, 2020
11th Annual Patient-Reported Outcome Consortium Workshop
The Eleventh Annual Patient-Reported Outcome Consortium Workshop will be on Wednesday, April 22 and Thursday, April 23, 2020 at the Sheraton Silver Spring, in Silver Spring MD. A detailed agenda and logistics are currently being developed and will be shared when available.
This Workshop is open to the public and requires registration. For questions or registration information please contact Janelle Russell.
-
April 6, 2020 - April 9, 2020
World Conference on Pharmacometrics
WHAT: World Conference on Pharmacometrics WHEN: April 6-9 2020 WHERE: Century City Conference Centre, Cape Town WCoP will be held April 6-9, 2020 at the Century City Conference Centre in Cape Town, South Africa. C-Path’s QuantMed program hosting a pre-conference workshop on the Role of Model Informed Drug Development (MIDD) in regulatory science. More information...... -
March 30, 2020 - March 31, 2020
2020 DIA Digital Technology in Clinical Trials Conference
The ePRO Consortium is pleased to be a co-sponsor of the upcoming 2020 DIA Digital Technology in Clinical Trials Conference to be held from March 30-31, 2020 in Boston, MA. This multi-track conference will bring together thought-leaders from regulatory agencies, biotech, pharmaceutical, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for...... -
March 18, 2020 - March 21, 2020
ASCPT Annual Meeting
WHAT: ASCPT Annual Meeting WHEN: March 18-21 2020 WHERE: Marriott Marquis, Houston, TX ASCPT Annual Meeting will be held March 18-21, 2020 at the Marriott Marquis in Houston, TX. A detailed program list can be found here. C-Path’s Klaus Romero speaking at the Translational and Clinical Pharmacology Advances in Anti-Infective Development on Wednesday March 18,...... -
October 29, 2019
2019 Annual Meeting and Regulatory Science Workshop
October 29, 2019 Crystal Gateway Marriott | Arlington, VA The key objectives of the meeting are: To discuss the proposed strategy for CPAD of developing comprehensive solutions for AD drug development, based on a quantitative understanding of disease progression across the entire AD continuum To review and define a path to advance the progress of......